Science Explorer Interactive view Map
Company · London · United Kingdom

BioMarin (United Kingdom)

biomarin.comROR OpenAlex
Research works
36
▲ 104% vs 2013–17
Citations
540
14.9 per fractional work
Top-10% rate
16.9%
record average 16.5%
Open access
67%
world 28%

Not ranked overall: BioMarin (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.52× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 0.92× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 5.45× its world share, 0 worksPharmacology, Toxico…Engineering: 0.05× its world share, 0 worksEngineeringMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 0.86× its world share, 0 worksMathematicsHealth Professions: 2.37× its world share, 1 worksHealth ProfessionsMedicine: 2.40× its world share, 9 worksMedicineNursing: 1.17× its world share, 0 worksNursingBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 5.11× its world share, 2 worksEconomics, Econometr…Psychology: 0.47× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.

Which keywords describe research at BioMarin (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Gene Therapy, Factor VIII, Hemophilia, Ehlers-Danlos Syndrome, Marfan Syndrome, Cost-effectiveness Analysis, Health Utility Measures and Quality of Life.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Gene Therapy3▲ 77×2 topics
  2. Factor VIII3▲ 929×1 topic
  3. Hemophilia3▲ 929×1 topic
  4. Ehlers-Danlos Syndrome2▲ 532×1 topic
  5. Marfan Syndrome2▲ 532×1 topic
  6. Cost-effectiveness Analysis2▲ 111×1 topic
  7. Health Utility Measures2▲ 111×1 topic
  8. Quality of Life2▲ 6.7×2 topics
  9. Newborn Screening1▲ 126×2 topics
  10. Biochemical Genetics1▲ 170×1 topic
  11. Epidemiology1▲ 1.46×9 topics
  12. Inflammation1▲ 2.9×9 topics
  13. Metabolic Disorders1▲ 50×1 topic
  14. Mitochondrial Function1▲ 65×2 topics

Which research topics does BioMarin (United Kingdom) publish most on?

By volume in 2022–2025: Hemophilia Treatment and Research, Connective tissue disorders research, Health Systems, Economic Evaluations, Quality of Life and Metabolism and Genetic Disorders.

Hemophilia Treatment and…3Hemophilia Treatment and Research: 3 fractional worksConnective tissue disord…2Connective tissue disorders research: 2 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 2 fractional worksMetabolism and Genetic D…1Metabolism and Genetic Disorders: 1 fractional worksGenomics and Rare Diseases: 1 fractional worksFolate and B Vitamins Research: 0 fractional worksAdolescent and Pediatric Healthcare: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksCoagulation, Bradykinin, Polyphosphates, and Angioedema: 0 fractional worksDermatological and Skeletal Disorders: 0 fractional works
HematologyGeneticsEconomics and EconometricsClinical Biochemistry3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hemophilia Treatment and Research Hematology 3 works
  2. 2 Connective tissue disorders research Genetics 2 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  4. 4 Metabolism and Genetic Disorders Clinical Biochemistry 1 works
  5. 5 Genomics and Rare Diseases Genetics 1 works
  6. 6 Folate and B Vitamins Research Rheumatology 0 works
  7. 7 Adolescent and Pediatric Healthcare Speech and Hearing 0 works
  8. 8 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  9. 9 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
  10. 10 Dermatological and Skeletal Disorders Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available67.2%not open32.8%

World: 28% of research is openly available.

with international co-authors67.1%domestic only32.9%

World: 19% is written across borders.

How has BioMarin (United Kingdom)'s research output changed?

Output in 2018–2022 was 104% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.